UK-based Pathios, a biotech company focused on treating autoimmune diseases and cancer, has raised $8.8 million in Series A financing. The investors were Canaan and Australia’s Medical Research Commercialisation Fund managed by Brandon Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: